Retrospective Study on the Effectiveness and Safety of Baricitinib in Treating Alopecia Areata

The retrospective study evaluated the effectiveness and safety of baricitinib in treating alopecia areata. The research was conducted by a team from Szegedi Tudományegyetem, including Zsolt Szász, Leó Asztalos, Lajos Kemény, and Rolland Gyulai. The study concluded that baricitinib is an effective treatment option for alopecia areata, with a favorable safety profile. The findings support the use of baricitinib as a viable therapeutic option for patients suffering from this condition. However, the document does not specify the number of participants involved in the study, which is crucial for assessing the strength of the study's conclusions.